{
    "code": "01049523",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01049523",
    "time": "2019-07-26 03:09:46",
    "許可證字號": "衛署藥製字第049523號",
    "註銷狀態": "已註銷",
    "註銷日期": "108\/06\/18",
    "註銷理由": "自請註銷",
    "有效日期": "107\/06\/20",
    "發證日期": "97\/06\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00104952302",
    "中文品名": "&quot;利達&quot; 衛胃康凍晶靜脈注射劑",
    "英文品名": "Omeprazole Lyo I.V. Injection 40mg &quot;Lita&quot;",
    "適應症": "下列病症無法以口服藥物有效治療時之取代療法：十二指腸潰瘍、胃潰瘍、逆流性食道炎、Zollinger-Ellison症。",
    "劑型": "243凍晶注射劑",
    "包裝": "40毫克小瓶裝 100支以下盒裝 各附等支數10毫升溶劑安瓿瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "OMEPRAZOLE SODIUM",
    "主製造廠": {
        "申請商名稱": "0701010200  利達製藥股份有限公司",
        "申請商地址": "台中市大甲區中山路一段９０６號",
        "主製造廠": "",
        "製造廠名稱": "0701010300  利達製藥股份有限公司"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5640002310",
            "成分名稱": "OMEPRAZOLE SODIUM",
            "含量描述": "(=Omeprazole 40mg)",
            "含量": "42.6000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛胃康凍晶靜脈注射劑之新仿單___20111206.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049523&Seq=002&Type=9"
        },
        {
            "title": "衛胃康凍晶靜脈注射劑之標籤___20111206.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049523&Seq=007&Type=8"
        }
    ]
}